InMed Pharmaceuticals (INM) Intangibles (2021 - 2025)
Historic Intangibles for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $2.9 million.
- InMed Pharmaceuticals' Intangibles changed 0.0% to $2.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.9 million for FY2025, which is 0.0% changed from last year.
- Per InMed Pharmaceuticals' latest filing, its Intangibles stood at $2.9 million for Q4 2025, which was down 0.0% from $2.9 million recorded in Q3 2025.
- InMed Pharmaceuticals' 5-year Intangibles high stood at $2.9 million for Q2 2023, and its period low was $1.7 million during Q3 2021.
- Over the past 5 years, InMed Pharmaceuticals' median Intangibles value was $2.9 million (recorded in 2023), while the average stood at $2.6 million.
- Its Intangibles has fluctuated over the past 5 years, first plummeted by 2519.48% in 2023, then surged by 4734.15% in 2024.
- Quarter analysis of 5 years shows InMed Pharmaceuticals' Intangibles stood at $2.7 million in 2021, then dropped by 23.68% to $2.0 million in 2022, then surged by 44.43% to $2.9 million in 2023, then changed by 0.0% to $2.9 million in 2024, then changed by 0.0% to $2.9 million in 2025.
- Its Intangibles stands at $2.9 million for Q4 2025, versus $2.9 million for Q3 2025 and $2.9 million for Q2 2025.